Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency

Ronald J. Rubocki, Jennifer R. Parsa, Michael S. Hershfield, Warren G. Sanger, Samuel J. Pirruccello, Ines Santisteban, Bruce G. Gordon, Sarah E. Strandjord, Phyllis I. Warkentin, Peter F. Coccia

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Bone marrow transplantation (BMT) for severe combined immunodeficiency (SCID) with human leukocyte antigen (HLA)-identical sibling donors but no pretransplantation cytoreduction results in T-lymphocyte engraftment and correction of immune dysfunction but not in full hematopoietic engraftment. A case of a 17-month-old girl with adenosine deaminase (ADA) deficiency SCID in whom full hematopoietic engraftment developed after BMT from her HLA-identical sister is reported. No myeloablative or immunosuppressive therapy or graft-versus-host disease (GVHD) prophylaxis was given. Mild acute and chronic GVHD developed, her B- and T-cell functions became reconstituted, and she is well almost 11 years after BMT. After BMT, repeated studies demonstrated: (1) Loss of a recipient-specific chromosomal marker in peripheral blood leukocytes (PBLs) and bone marrow, (2) conversion of recipient red blood cell antigens to donor type, (3) conversion of recipient T-cell, B-cell, and granulocyte lineages to donor origin by DNA analysis, and (4) increased ADA activity and metabolic correction in red blood cells and PBLs.

Original languageEnglish (US)
Pages (from-to)809-811
Number of pages3
JournalBlood
Volume97
Issue number3
DOIs
StatePublished - Feb 1 2001

Fingerprint

Severe Combined Immunodeficiency
Homologous Transplantation
Bone Marrow Transplantation
Bone
T-cells
Blood
Tissue Donors
Graft vs Host Disease
HLA Antigens
T-Lymphocytes
Adenosine Deaminase
Cells
Siblings
Leukocytes
Grafts
Erythrocytes
Cell Lineage
Immunosuppressive Agents
Granulocytes
B-Lymphocytes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency. / Rubocki, Ronald J.; Parsa, Jennifer R.; Hershfield, Michael S.; Sanger, Warren G.; Pirruccello, Samuel J.; Santisteban, Ines; Gordon, Bruce G.; Strandjord, Sarah E.; Warkentin, Phyllis I.; Coccia, Peter F.

In: Blood, Vol. 97, No. 3, 01.02.2001, p. 809-811.

Research output: Contribution to journalArticle

Rubocki, Ronald J. ; Parsa, Jennifer R. ; Hershfield, Michael S. ; Sanger, Warren G. ; Pirruccello, Samuel J. ; Santisteban, Ines ; Gordon, Bruce G. ; Strandjord, Sarah E. ; Warkentin, Phyllis I. ; Coccia, Peter F. / Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency. In: Blood. 2001 ; Vol. 97, No. 3. pp. 809-811.
@article{615c1f79eab54e10883a70ab626dd379,
title = "Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency",
abstract = "Bone marrow transplantation (BMT) for severe combined immunodeficiency (SCID) with human leukocyte antigen (HLA)-identical sibling donors but no pretransplantation cytoreduction results in T-lymphocyte engraftment and correction of immune dysfunction but not in full hematopoietic engraftment. A case of a 17-month-old girl with adenosine deaminase (ADA) deficiency SCID in whom full hematopoietic engraftment developed after BMT from her HLA-identical sister is reported. No myeloablative or immunosuppressive therapy or graft-versus-host disease (GVHD) prophylaxis was given. Mild acute and chronic GVHD developed, her B- and T-cell functions became reconstituted, and she is well almost 11 years after BMT. After BMT, repeated studies demonstrated: (1) Loss of a recipient-specific chromosomal marker in peripheral blood leukocytes (PBLs) and bone marrow, (2) conversion of recipient red blood cell antigens to donor type, (3) conversion of recipient T-cell, B-cell, and granulocyte lineages to donor origin by DNA analysis, and (4) increased ADA activity and metabolic correction in red blood cells and PBLs.",
author = "Rubocki, {Ronald J.} and Parsa, {Jennifer R.} and Hershfield, {Michael S.} and Sanger, {Warren G.} and Pirruccello, {Samuel J.} and Ines Santisteban and Gordon, {Bruce G.} and Strandjord, {Sarah E.} and Warkentin, {Phyllis I.} and Coccia, {Peter F.}",
year = "2001",
month = "2",
day = "1",
doi = "10.1182/blood.V97.3.809",
language = "English (US)",
volume = "97",
pages = "809--811",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "3",

}

TY - JOUR

T1 - Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency

AU - Rubocki, Ronald J.

AU - Parsa, Jennifer R.

AU - Hershfield, Michael S.

AU - Sanger, Warren G.

AU - Pirruccello, Samuel J.

AU - Santisteban, Ines

AU - Gordon, Bruce G.

AU - Strandjord, Sarah E.

AU - Warkentin, Phyllis I.

AU - Coccia, Peter F.

PY - 2001/2/1

Y1 - 2001/2/1

N2 - Bone marrow transplantation (BMT) for severe combined immunodeficiency (SCID) with human leukocyte antigen (HLA)-identical sibling donors but no pretransplantation cytoreduction results in T-lymphocyte engraftment and correction of immune dysfunction but not in full hematopoietic engraftment. A case of a 17-month-old girl with adenosine deaminase (ADA) deficiency SCID in whom full hematopoietic engraftment developed after BMT from her HLA-identical sister is reported. No myeloablative or immunosuppressive therapy or graft-versus-host disease (GVHD) prophylaxis was given. Mild acute and chronic GVHD developed, her B- and T-cell functions became reconstituted, and she is well almost 11 years after BMT. After BMT, repeated studies demonstrated: (1) Loss of a recipient-specific chromosomal marker in peripheral blood leukocytes (PBLs) and bone marrow, (2) conversion of recipient red blood cell antigens to donor type, (3) conversion of recipient T-cell, B-cell, and granulocyte lineages to donor origin by DNA analysis, and (4) increased ADA activity and metabolic correction in red blood cells and PBLs.

AB - Bone marrow transplantation (BMT) for severe combined immunodeficiency (SCID) with human leukocyte antigen (HLA)-identical sibling donors but no pretransplantation cytoreduction results in T-lymphocyte engraftment and correction of immune dysfunction but not in full hematopoietic engraftment. A case of a 17-month-old girl with adenosine deaminase (ADA) deficiency SCID in whom full hematopoietic engraftment developed after BMT from her HLA-identical sister is reported. No myeloablative or immunosuppressive therapy or graft-versus-host disease (GVHD) prophylaxis was given. Mild acute and chronic GVHD developed, her B- and T-cell functions became reconstituted, and she is well almost 11 years after BMT. After BMT, repeated studies demonstrated: (1) Loss of a recipient-specific chromosomal marker in peripheral blood leukocytes (PBLs) and bone marrow, (2) conversion of recipient red blood cell antigens to donor type, (3) conversion of recipient T-cell, B-cell, and granulocyte lineages to donor origin by DNA analysis, and (4) increased ADA activity and metabolic correction in red blood cells and PBLs.

UR - http://www.scopus.com/inward/record.url?scp=0035253818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035253818&partnerID=8YFLogxK

U2 - 10.1182/blood.V97.3.809

DO - 10.1182/blood.V97.3.809

M3 - Article

C2 - 11157502

AN - SCOPUS:0035253818

VL - 97

SP - 809

EP - 811

JO - Blood

JF - Blood

SN - 0006-4971

IS - 3

ER -